Orchard Therapeutics plc - ROE
ORTX
Price:
$16.7
Market Cap:
$380.11M
Orchard Therapeutics plc is a biopharmaceutical firm dedicated to developing gene-based treatments for severe and often fatal rare conditions, operating across the United Kingdom, European Union, and the United States. Their innovative gene therapy strategy involves modifying a patient's own hematopoietic stem cells, converting them into a therapeutic cellular drug that can address the illness with just one dose. The company markets Strimvelis, a gammaretroviral therapy approved for treating adenosine deaminase-severe combined immunodeficiency (ADA-SCID). Orchard's clinical pipeline features several investigational therapies, including OTL-101 for ADA-SCID, OTL-200 targeting metachromatic le...[Read more]
Industry
Biotechnology
IPO Date
2018-10-31
Stock Exchange
NASDAQ
Ticker
ORTX
PE Ratio
[-4.07]
ROE
[-5.12%]
Current Ratio
[2.78]
Dividend Yield
[0%]
Enterprise Value
[369.77M]
Dividend History
The ROE as of June 2026 (TTM) for Orchard Therapeutics plc (ORTX) is -5.12%
According to Orchard Therapeutics plc’s latest financial reports and current stock price. The company's current ROE is -5.12%. This represents a change of -131.55% compared to the average of 16.21% of the last 4 quarters.
Orchard Therapeutics plc (ORTX) Historical ROE (quarterly & annually)
How has ORTX ROE performed in the past?
The mean historical ROE of Orchard Therapeutics plc over the last ten years is -24.24%. The current -5.12% ROE has changed -78.90% with respect to the historical average. Over the past ten years (40 quarters), ORTX's ROE was at its highest in in the December 2022 quarter at 137.28%. The ROE was at its lowest in in the June 2018 quarter at -1059.49%.
Average
-24.24%
Median
-46.00%
Minimum
-85.17%
Maximum
115.50%
Orchard Therapeutics plc (ORTX) ROE by Quarter and Year
Discovering the peaks and valleys of Orchard Therapeutics plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 60.95%
Maximum Annual ROE = 115.50%
Minimum Annual Increase = -139.82%
Minimum Annual ROE = -85.17%
| Year | ROE | Change |
|---|---|---|
| 2022 | -8.02% | -53.66% |
| 2021 | -17.31% | -79.67% |
| 2020 | -85.17% | 55.94% |
| 2019 | -54.62% | -26.22% |
| 2018 | -74.03% | 60.95% |
| 2017 | -46.00% | -139.82% |
Orchard Therapeutics plc (ORTX) Average ROE
How has ORTX ROE performed in the past?
The current ROE of Orchard Therapeutics plc (ORTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-36.84%
5-year avg
-47.83%
10-year avg
-24.24%
Orchard Therapeutics plc (ORTX) ROE vs. Peers
How is ORTX’s ROE compared to its peers?
Orchard Therapeutics plc’s ROE is greater than Vigil Neuroscience, Inc. (-122.87%), greater than Checkpoint Therapeutics, Inc. (-2185.94%), less than Revance Therapeutics, Inc. (466.15%), greater than G1 Therapeutics, Inc. (-92.13%), greater than Climb Bio, Inc. (-31.46%), greater than Y-mAbs Therapeutics, Inc. (-16.98%), less than scPharmaceuticals Inc. (1.29%), greater than iTeos Therapeutics, Inc. (-28.60%), greater than SomaLogic, Inc. (-18.59%), less than Claritev Corporation (205.84%),
| Company | ROE | Market cap |
|---|---|---|
| -122.87% | $375.71M | |
| -2185.94% | $367.72M | |
| 466.15% | $381.02M | |
| -92.13% | $377.75M | |
| -31.46% | $780.71M | |
| -16.98% | $391.22M | |
| 1.29% | $302.20M | |
| -28.60% | $448.68M | |
| -18.59% | $396.23M | |
| 205.84% | $501.55M |
Build a custom stock screener for Orchard Therapeutics plc (ORTX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orchard Therapeutics plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Orchard Therapeutics plc (ORTX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Orchard Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Orchard Therapeutics plc's ROE?
How is the ROE calculated for Orchard Therapeutics plc (ORTX)?
What is the highest ROE for Orchard Therapeutics plc (ORTX)?
What is the 3-year average ROE for Orchard Therapeutics plc (ORTX)?
What is the 5-year average ROE for Orchard Therapeutics plc (ORTX)?
How does the current ROE for Orchard Therapeutics plc (ORTX) compare to its historical average?